G
GDBYF
vs
S&P 500
S&P 500
Over the past 12 months, GDBYF has underperformed S&P 500, delivering a return of 0% compared to the S&P 500's +15% growth.
Stocks Performance
GDBYF vs S&P 500
Performance Gap
GDBYF vs S&P 500
Performance By Year
GDBYF vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Goodbody Health Inc
Glance View
Goodbody Health, Inc. operates as a health and wellness company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2015-09-21. The firm operates both in wellness testing in the United Kingdom and as a vertically integrated cannabinoid (CBD) company that operates in the United Kingdom and the European Union. The company operates under one segment: the sale of cannabinoid products and clinic and cannabinoid testing. The firm focuses on offering COVID and blood testing clinics, CBD extraction, wholesale bulk isolate and distillate sales, retail CBD and white label sales, cannabinoid laboratory testing, and medicinal cannabis research programs. The company provides a local level network of approximately 140 clinics, providing over 30 blood and polymerase chain reaction (PCR) tests for at home or in clinic testing. The Company’s subsidiaries include Borganic, Olimax, Olimax RE, Sativa Wellness Group Poland, Sativa Group, Goodbody Botanicals and Phytovista Laboratories.
